Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 190
Endocrine and Metabolic Disorders Drugs 162
Gastrointestinal Drugs 146
Central Nervous System Drugs 127
Immune Disorders Drugs 127
Biopharmaceuticals 85
Pharmaceuticals 84
Hematological Drugs 78
Vaccines 78
Clinical Trials 68
Drug Discovery 63
Cardiovascular Drugs 60
Diabetes Drugs 56
Infectious Diseases Drugs 56
Leukemia Drugs 52
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 41
Liver and Kidney Disorders Drugs 32
Infusions and Injectables 31
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 23
Pharmaceutical Manufacturing 20
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 18
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Thyroid Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Transdermal and Transmucosal Drug Delivery 5
Uterine Cancer Drugs 5
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Cough and Cold Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



282 reviews

1,637 Results (Page 30 of 82)
- Relevance
  Sort by

Opioid Antagonist Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Application, Product Type

 Report
January 2024
100 Pages
Global

From

€3500EUR$4,223USD£3,140GBP

Endometrial Cancer Treatment Market Report 2026

 Report
February 2026
250 Pages
Global

From

€3986EUR$4,490USD£3,454GBP

Pharma and ESG: The Patient Perspective, 2023 - The Views of 832 Patient Groups from Around the World

 Report
November 2023
63 Pages
Global

€8359EUR$9,746USD£7,000GBP

Oral Anti-Diabetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
150 Pages
Global

From

€4217EUR$4,750USD£3,655GBP

Japan Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Japan

From

€4217EUR$4,750USD£3,655GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Italy Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Italy

From

€4217EUR$4,750USD£3,655GBP

India Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
India

From

€4217EUR$4,750USD£3,655GBP

New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4217EUR$4,750USD£3,655GBP

Europe Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Europe

From

€4217EUR$4,750USD£3,655GBP

Asia-Pacific Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Asia Pacific

From

€4217EUR$4,750USD£3,655GBP

South Africa Oral Antidiabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
South Africa

From

€4217EUR$4,750USD£3,655GBP

Endocrinology Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4217EUR$4,750USD£3,655GBP

Fabry Disease Treatment - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
106 Pages
Global

From

€4217EUR$4,750USD£3,655GBP

New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4217EUR$4,750USD£3,655GBP

North America Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
North America

From

€4217EUR$4,750USD£3,655GBP

Latin America Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Latin America

From

€4217EUR$4,750USD£3,655GBP

Cervical Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
700 Pages
Global

From

€2219EUR$2,500USD£1,923GBP

Aurora-A Kinase Inhibitors - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1332EUR$1,500USD£1,154GBP

BRAFV600 Mutation (B-Raf Proto-oncogene, Serine/threonine Kinase) Inhibiotors - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1332EUR$1,500USD£1,154GBP

CCR2 Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1332EUR$1,500USD£1,154GBP

1,637 Results (Page 30 of 82)
- 1
- 28
- 29
- 30
- 31
- 32

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.